Age, years, median and IQR 55 (46-65)
Female, n (%) 63 (87.5)
dcSSc, n (%) 33 (45.8)
Disease duration, years, median and IQR 11 (6-20)
mRSS, median and IQR 13 (7-18)
SSc-specific autoantibodies:
Anti-topoisomerase I, n (%) 33 (45.8)
Anti-centromere, n (%) 24 (33.3)
Anti-RNA polymerase III, n (%) 4 (5.6)
None, n (%) 11 (15.3)
DAI, median and IQR 1.5 (0.8-2.9)
DSS. median and IQR 5 (4-6)
Telangiectasias, n (%) 38 (52.8%)
ESR, mm/h, median and IQR 19 (12-34)
CRP, mcg/L, median and IQR 1600 (800-3500)
C3, mg/L, median and IQR 1045 (925-1180)
Nailfold capillaroscopic pattern:
Early, n (%) 13 (18.1)
Active, n (%) 23 (31.9)
Late, n (%) 36 (50)
sCr, mg/dL, median and IQR 0.8 (0.6-0.9)
eGFR, mL/min, median and IQR 93 (80-108)
Arterial hypertension, n (%) 22 (30.6%)